Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030

This document presents the major issues that were discussed in the process of working towards the development of a new medicines policy in Saudi Arabia, examining current national practice in light of international practices and experiences. The document is designed to foster discussion and help inform the development of a new national medicine policy. A detailed accounting of the evidence informing policy choices to be highlighted in an updated medicine policy are presented in Part I of this discussion paper; a proposed new National Medicine Policy itself is presented in Part ll. A new Medicine policy, once finalized and approved, will need to be implemented in a highly dynamic environment and must therefore allow for flexibility. It will need to be followed by the implementation of regulations, closely monitored, and adapted as necessary over time.

Saved in:
Bibliographic Details
Main Authors: Alghaith, Taghred, Almoteiry, Khalid, Alamri, Adwa, Alluhidan, Mohammed, Alharf, Adel, Al-Hammad, Bander, Aliafali, Ibrahim, Seiter, Andreas, Pisani, Elizabeth, Herbst, Christopher H., El-Saharty, Sameh, Alazemi, Nahar
Format: Working Paper biblioteca
Language:English
Published: World Bank, Washington, DC 2020
Subjects:PHARMACEUTICAL SYSTEM, MEDICINE POLICY, ACCESS TO HEALTH CARE, MEDICINE PRICING, PHARMACEUTICAL INDUSTRY,
Online Access:http://documents.worldbank.org/curated/en/305991624017831749/Strengthening-the-Pharmaceutical-System-in-the-Kingdom-of-Saudi-Arabia-Towards-a-Medicine-Policy-to-Support-Vision-2030
http://hdl.handle.net/10986/35846
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items